XML 52 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Notional Amounts of Derivative Instruments

The table below presents the total volume or notional amounts of the Company’s derivative instruments as of September 30, 2017. Notional values are in U.S. dollars and are translated and calculated based on forward rates as of September 30, 2017 for forward contracts, and based on spot rates as of September 30, 2017 for options.

 

     Notional Value*  

Foreign exchange contracts

   $ 1,235,838  

 

(*) Gross notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of settlements under the contracts.
Fair Value of Open Foreign Currency Exchange Contracts

The fair value of the open foreign exchange contracts recorded as an asset or a liability by the Company on its consolidated balance sheets as of September 30, 2017 and September 30, 2016, is as follows:

 

     As of September 30,  
     2017      2016  

Derivatives designated as hedging instruments

     

Prepaid expenses and other current assets

   $ 30,141      $ 12,780  

Other noncurrent assets

     1,091        4,545  

Accrued expenses and other current liabilities

     (2,317      (501

Other noncurrent liabilities

     (1,035      (367
  

 

 

    

 

 

 
     27,880      16,457  

Derivatives not designated as hedging instruments

     

Prepaid expenses and other current assets

     2,840        3,516  

Accrued expenses and other current liabilities

     (3,368      (3,906
  

 

 

    

 

 

 
     (528)      (390)  
  

 

 

    

 

 

 

Net fair value

   $ 27,352      $ 16,067  
  

 

 

    

 

 

 
Effect of Cash Flow Hedging Instruments

The effect of the Company’s cash flow hedging instruments in the consolidated statements of income for the fiscal years ended September 30, 2017, 2016 and 2015, respectively, which partially offsets the foreign currency impact from the underlying exposures, is summarized as follows:

 

     Gains (Losses) Reclassified from

Other Comprehensive Income 

(Loss) (Effective Portion)

Year Ended September 30,
 
     2017      2016      2015  

Line item in consolidated statements of income:

        

Revenue

   $ (1,021    $ (192    $ 1,077  

Cost of revenue

     21,783        (2,131      (13,624

Research and development

     4,282        (643      (3,621

Selling, general and administrative

     3,305        (1,175      (4,074
  

 

 

    

 

 

    

 

 

 

Total

   $ 28,349      $ (4,141    $ (20,242
  

 

 

    

 

 

    

 

 

 
Changes in Net Unrealized Gains (Losses) on Cash Flow Hedges

The activity related to the changes in net unrealized gains (losses) on cash flow hedges recorded in accumulated other comprehensive income (loss), net of tax, is as follows:

 

     Year Ended September 30,  
     2017      2016      2015  

Net unrealized gains (losses) on cash flow hedges, net of tax, beginning of period

   $ 12,514      $ (12,152    $ (5,522

Changes in fair value of cash flow hedges, net of tax

     36,765        20,911        (23,432

Reclassification of (gains) losses into earnings, net of tax

     (24,771      3,755        16,802  
  

 

 

    

 

 

    

 

 

 

Net unrealized gains (losses) on cash flow hedges, net of tax, end of period

   $ 24,508      $ 12,514      $ (12,152
  

 

 

    

 

 

    

 

 

 
Effect of Non-Designated as Hedging Instruments

The effect of the Company’s derivative instruments not designated as hedging instruments in the consolidated statements of income for the fiscal years ended September 30, 2017, 2016 and 2015, respectively, which partially offsets the foreign currency impact from the underlying exposure, is summarized as follows:

 

     (Losses) Gains
Recognized in Income
Year Ended September 30,
 
     2017      2016      2015  

Line item in statements of income:

        

Revenue

   $ —        $ (67    $ 339  

Cost of revenue

     4,639        2,187        (8,668

Research and development

     957        284        (830

Selling, general and administrative

     1,723        560        (1,827

Interest and other (expense) income, net

     (10,514      (9,674      30,150  

Income taxes

     (1,653      (1,076      1,822  
  

 

 

    

 

 

    

 

 

 

Total

   $ (4,848    $ (7,786    $ 20,986